MedPath

A study on immune cell exhaustion in patients with type 2 diabetes

Not Applicable
Conditions
type 2 diabetes
Registration Number
JPRN-UMIN000041917
Lead Sponsor
Department of Endocrinology and Metabolism, Dokkyo Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

1) patients with active chronic infectious diseases such as tuberculosis 2) patients with acute infectious diseases such as pneumonia 3) patients with history of chronic inflammatorys diseases such as rheumatoid arthritis 4) patients with history of cancer 5) immunodeficient patients such as those with AIDS 6) patients taking immunosuppressant, steroids, and anti-cancer drugs 7) pregnant, potentially pregnant or lactating women 8) patients with moderate renal dysfunction (male serum creatinin 1.3 mg/dL or higher, female 1.2 mg/dL or higher)

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the expression levels of co-inhibitors on peripheral blood T lymphocytes between type 2 diabetes and non-diabetic patients
Secondary Outcome Measures
NameTimeMethod
To compare the expression levels of co-inhibitors on peripheral blood T lymphocytes before and after the improvement of blood glucose level in type 2 diabetes patients
© Copyright 2025. All Rights Reserved by MedPath